Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.

[1]  A. Palache,et al.  Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective. , 2011, Vaccine.

[2]  G. Van Domselaar,et al.  Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus. , 2010, Biochemical and biophysical research communications.

[3]  S. Khurana,et al.  Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets , 2010, Journal of Virology.

[4]  S. Khurana,et al.  Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus , 2010, PloS one.

[5]  R. Stout,et al.  An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. , 2010, Vaccine.

[6]  Xuguang Li,et al.  Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[7]  Derek Gatherer,et al.  The 2009 H1N1 influenza outbreak in its historical context. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  Yi Guan,et al.  Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  Gavin J. D. Smith,et al.  Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic , 2009, Nature.

[10]  K. Subbarao,et al.  Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets , 2009, PLoS medicine.

[11]  J. Kapteyn,et al.  HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. , 2009, Vaccine.

[12]  J. Frank,et al.  SPIDER image processing for single-particle reconstruction of biological macromolecules from electron micrographs , 2008, Nature Protocols.

[13]  G. Van Domselaar,et al.  Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. , 2008, Vaccine.

[14]  N. Cox,et al.  Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. , 2008, Vaccine.

[15]  Wei Shi,et al.  Comparative Efficacy of Neutralizing Antibodies Elicited by Recombinant Hemagglutinin Proteins from Avian H5N1 Influenza Virus , 2008, Journal of Virology.

[16]  Michel Girard,et al.  Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. , 2007, Analytical chemistry.

[17]  C. Gerdil.  The annual production cycle for influenza vaccine. , 2003, Vaccine.

[18]  W. Blackwelder,et al.  Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. , 2001, Vaccine.

[19]  W Chiu,et al.  EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.

[20]  R. Betts,et al.  Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. , 1996, The Journal of infectious diseases.

[21]  J. Skehel,et al.  Electron microscopy of the low pH structure of influenza virus haemagglutinin. , 1986, The EMBO journal.

[22]  I. Wilson,et al.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.

[23]  F. Ennis,et al.  New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion. , 1980, Journal of biological standardization.

[24]  V. Seagroatt,et al.  An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. , 1977, Journal of biological standardization.

[25]  J. Skehel,et al.  Crystalline antigen from the influenza virus envelope. , 1972, Nature: New biology.

[26]  H. Klenk,et al.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. , 1970, Virology.

[27]  Update: influenza activity - United States, 2009-10 season. , 2010, MMWR. Morbidity and mortality weekly report.

[28]  N. Khardori,et al.  Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 , 2009 .

[29]  J Bernard Heymann,et al.  Bsoft: image processing and molecular modeling for electron microscopy. , 2007, Journal of structural biology.

[30]  J. Wood,et al.  The influence of the host cell on standardisation of influenza vaccine potency. , 1999, Developments in biological standardization.